Wilms Tümörü
Özet
Referanslar
Kara B. Çocuklarda primer böbrek tümörlerinin klinik özellikleri, tedavi yaklaşımları ve tedavi sonuçları. Genel Tıp Dergisi. 2021;31(4):375–379.
Pater L, Melchior P, Rübe H, et al. Wilms tümörü. Türk Onkoloji Dergisi. 2021;68(Ek 2):1–7.
Yıldız I. Treatment of Wilms Tumor: A Report from the Turkish Pediatric Oncology Group (TPOG). Turkish Journal of Oncology. 2010;(October 2009):161–178.
Nakayama D,Patrick C. The History of Multimodal Treatment of Wilms’ Tumor. World Journal of Oncology Research. 2016;:487–492.
Libes J, Hol J, Caetano J, et al. Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges. Cancer Epidemiology. 2023;(August 2022):1–10.
Turner JT, Brzezinski J, Dome JS. Wilms Tumor Predisposition. Current Opinion in Pediatrics. 2025;1–14.
Tang F, Zhang H, Lu Z, et al. Prognostic Factors and Nomograms to Predict Overall and Cancer-Specific Survival for Children with Wilms’ Tumor. BioMed Research International. 2019;2019:9267436.1-10.doi: 10.1155/2019/9267436
Spreafico F, Fernandez CV, Brok J, et al. Wilms tumour. Nature Reviews Disease Primers. 2021;7(1):75.1-20 doi: 10.1038/s41572-021-00308-8
Elgenidy A, Afifi AM, Gad EF, et al. Survival characteristics of Wilms Tumor, a reference developed from a longitudinal cohort study. BMC Cancer. 2024;24:487.
User İR, Ekinci S. Wilms tümörü: Çocuk cerrahı gözüyle güncel yaklaşımlar ve tedavideki sorunlar. Türk Cerrahi Dergisi. 2016;30(3):433–440.
Nelson MV, Graf N, Dome JS, et al. HHS Public Access. Journal of Clinical Oncology. 2022;33(1):40–48.
Zheng H, Liu J, Pan X, et al. Biomarkers for patients with Wilms tumor: a review. Frontiers in Oncology. 2023;13:1234567.
Hol JA, Diets IJ, De Krijger RR, et al. TRIM28 variants and Wilms’ tumour predisposition. European Journal of Human Genetics. 2021;29:494–504.
Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one‐third of tumors. Genes, Chromosomes & Cancer. 2008;47(6):461–470.doi: 10.1002/gcc.20553
Shojaeian R, Hiradfar M, Sharifabad PS, et al. Extrarenal Wilms’ Tumor: Challenges in Diagnosis, Embryology, Treatment and Prognosis. In: Wilms Tumor. Codon Publications; 2016. p. 77–93.doi: 10.15586/wt.2016.ch6
Deng C, Dai R, Li X, et al. Genetic variation frequencies in Wilms’ tumor: A meta-analysis and systematic review. Oncology Letters. 2016;12(2):1193–1200.doi: 10.3892/ol.2016.4763
Parsons LN. Wilms Tumor. Surgical Pathology. 2025;13(4):683–693.doi: 10.1016/j.path.2020.08.007
Benedetti DJ, Cost NG, Ehrlich PF, et al. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials. Nature Reviews Urology. 2025;22:1–11.doi: 10.1038/s41585-025-01055-1
Wu J, Yan H, Xiang C, et al. Wilms’ tumor gene 1 in hematological malignancies: friend or foe? Leukemia & Lymphoma. 2023;64(7):8454–8462.
Dome JS, Fernandez CV, Mullen EA, et al. NIH Public Access. Journal of Clinical Oncology. 2014;60(6):994–1000.
Sarin YK, Bhatnagar SN. Wilms’ Tumor- Roadmaps of Management. Indian Journal of Pediatrics. 2012;79(June):776–786.doi: 10.1007/s12098-012-0713-9
Treger TD, Chagtai T, Butcher R, et al. Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors. Translational Oncology. 2018;11(6):1301–1306.doi: 10.1016/j.tranon.2018.08.012
Fukuda A, Isoda T, Sakamoto N, et al. Lessons from a patient with cardiac arrest due to massive pulmonary embolism as the initial presentation of Wilms tumor: a case report and literature review. Journal of Pediatric Hematology/Oncology. 2019;41(2):e105–e108.
Karim A, Shaikhyzada K, Abulkhanova N, et al. Systematic Case-Based Review. BMC Pediatrics. 2023;23:310.
Milford K, Decotiis K, Lorenzo A, et al. Wilms tumor: a review of current surgical controversies. World Journal of Pediatric Surgery. 2020;3:e000144.
Tumor W, Literature C. Wilms Tümörü: Tek Merkezin 32 Yıllık Deneyimleri ile Güncel Literatürün Gözden Geçirilmesi. Journal of Pediatric Surgery. 2021;13(3):1–9.
Murphy AJ, Davidoff AM. Wilms tumor. Seminars in Pediatric Surgery. 2023;32(1):151289.
Yalçın k.Wilms tümöründe parsiyel nefrektomi.Grand Journal of ürology. 2024:
25-27
Anomal T, Group A. Pediyatrik yaş grubunda laparoskopik nefrektomi, parsiyel nefrektomi, ürogenital trakt anomalilerinin tedavisinde laparoskopi. Turkish Journal of Surgery. 2022;38(1):91–95.
Mavinkurve-Groothuis AMC, Herrera TBV. Advances in the Clinical Management of High-Risk Wilms Tumors. Current Opinion in Oncology. 2024;70(Suppl 2):1–20.
Elmali A, Yüce Sari S, Akyüz C, et al. De-escalated Radiotherapy for Advanced Stage Wilms’ Tumor. Turk Onkoloji Dergisi. 2023;38(1):66–74.
Hong B, Dong R. Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review. Translational Cancer Research. 2021;10(3):1559–1567.doi: 10.21037/tcr-21-413
Groenendijk A, Spreafico F, De Krijger RR, et al. Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. Cancer Treatment Reviews. 2021;98:102211.
Referanslar
Kara B. Çocuklarda primer böbrek tümörlerinin klinik özellikleri, tedavi yaklaşımları ve tedavi sonuçları. Genel Tıp Dergisi. 2021;31(4):375–379.
Pater L, Melchior P, Rübe H, et al. Wilms tümörü. Türk Onkoloji Dergisi. 2021;68(Ek 2):1–7.
Yıldız I. Treatment of Wilms Tumor: A Report from the Turkish Pediatric Oncology Group (TPOG). Turkish Journal of Oncology. 2010;(October 2009):161–178.
Nakayama D,Patrick C. The History of Multimodal Treatment of Wilms’ Tumor. World Journal of Oncology Research. 2016;:487–492.
Libes J, Hol J, Caetano J, et al. Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges. Cancer Epidemiology. 2023;(August 2022):1–10.
Turner JT, Brzezinski J, Dome JS. Wilms Tumor Predisposition. Current Opinion in Pediatrics. 2025;1–14.
Tang F, Zhang H, Lu Z, et al. Prognostic Factors and Nomograms to Predict Overall and Cancer-Specific Survival for Children with Wilms’ Tumor. BioMed Research International. 2019;2019:9267436.1-10.doi: 10.1155/2019/9267436
Spreafico F, Fernandez CV, Brok J, et al. Wilms tumour. Nature Reviews Disease Primers. 2021;7(1):75.1-20 doi: 10.1038/s41572-021-00308-8
Elgenidy A, Afifi AM, Gad EF, et al. Survival characteristics of Wilms Tumor, a reference developed from a longitudinal cohort study. BMC Cancer. 2024;24:487.
User İR, Ekinci S. Wilms tümörü: Çocuk cerrahı gözüyle güncel yaklaşımlar ve tedavideki sorunlar. Türk Cerrahi Dergisi. 2016;30(3):433–440.
Nelson MV, Graf N, Dome JS, et al. HHS Public Access. Journal of Clinical Oncology. 2022;33(1):40–48.
Zheng H, Liu J, Pan X, et al. Biomarkers for patients with Wilms tumor: a review. Frontiers in Oncology. 2023;13:1234567.
Hol JA, Diets IJ, De Krijger RR, et al. TRIM28 variants and Wilms’ tumour predisposition. European Journal of Human Genetics. 2021;29:494–504.
Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one‐third of tumors. Genes, Chromosomes & Cancer. 2008;47(6):461–470.doi: 10.1002/gcc.20553
Shojaeian R, Hiradfar M, Sharifabad PS, et al. Extrarenal Wilms’ Tumor: Challenges in Diagnosis, Embryology, Treatment and Prognosis. In: Wilms Tumor. Codon Publications; 2016. p. 77–93.doi: 10.15586/wt.2016.ch6
Deng C, Dai R, Li X, et al. Genetic variation frequencies in Wilms’ tumor: A meta-analysis and systematic review. Oncology Letters. 2016;12(2):1193–1200.doi: 10.3892/ol.2016.4763
Parsons LN. Wilms Tumor. Surgical Pathology. 2025;13(4):683–693.doi: 10.1016/j.path.2020.08.007
Benedetti DJ, Cost NG, Ehrlich PF, et al. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials. Nature Reviews Urology. 2025;22:1–11.doi: 10.1038/s41585-025-01055-1
Wu J, Yan H, Xiang C, et al. Wilms’ tumor gene 1 in hematological malignancies: friend or foe? Leukemia & Lymphoma. 2023;64(7):8454–8462.
Dome JS, Fernandez CV, Mullen EA, et al. NIH Public Access. Journal of Clinical Oncology. 2014;60(6):994–1000.
Sarin YK, Bhatnagar SN. Wilms’ Tumor- Roadmaps of Management. Indian Journal of Pediatrics. 2012;79(June):776–786.doi: 10.1007/s12098-012-0713-9
Treger TD, Chagtai T, Butcher R, et al. Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors. Translational Oncology. 2018;11(6):1301–1306.doi: 10.1016/j.tranon.2018.08.012
Fukuda A, Isoda T, Sakamoto N, et al. Lessons from a patient with cardiac arrest due to massive pulmonary embolism as the initial presentation of Wilms tumor: a case report and literature review. Journal of Pediatric Hematology/Oncology. 2019;41(2):e105–e108.
Karim A, Shaikhyzada K, Abulkhanova N, et al. Systematic Case-Based Review. BMC Pediatrics. 2023;23:310.
Milford K, Decotiis K, Lorenzo A, et al. Wilms tumor: a review of current surgical controversies. World Journal of Pediatric Surgery. 2020;3:e000144.
Tumor W, Literature C. Wilms Tümörü: Tek Merkezin 32 Yıllık Deneyimleri ile Güncel Literatürün Gözden Geçirilmesi. Journal of Pediatric Surgery. 2021;13(3):1–9.
Murphy AJ, Davidoff AM. Wilms tumor. Seminars in Pediatric Surgery. 2023;32(1):151289.
Yalçın k.Wilms tümöründe parsiyel nefrektomi.Grand Journal of ürology. 2024:
25-27
Anomal T, Group A. Pediyatrik yaş grubunda laparoskopik nefrektomi, parsiyel nefrektomi, ürogenital trakt anomalilerinin tedavisinde laparoskopi. Turkish Journal of Surgery. 2022;38(1):91–95.
Mavinkurve-Groothuis AMC, Herrera TBV. Advances in the Clinical Management of High-Risk Wilms Tumors. Current Opinion in Oncology. 2024;70(Suppl 2):1–20.
Elmali A, Yüce Sari S, Akyüz C, et al. De-escalated Radiotherapy for Advanced Stage Wilms’ Tumor. Turk Onkoloji Dergisi. 2023;38(1):66–74.
Hong B, Dong R. Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review. Translational Cancer Research. 2021;10(3):1559–1567.doi: 10.21037/tcr-21-413
Groenendijk A, Spreafico F, De Krijger RR, et al. Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. Cancer Treatment Reviews. 2021;98:102211.
